ClinicalTrials.gov
public full text
Public Domain
Long-term Extension Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia
The study evaluates the long term safety and efficacy of SM-13496 in patients with schizophrenia.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- 52-week Open Label Safety-Tolerability Study#830078
- Comparison of the Efficacy and Safety of Risperidone Versus Risperidone Plus Low Dose of Haloperidol in the Treatment of Schizophrenia#1339526
- Early Prediction of Clinical Response in Patients With Schizophrenia Treated by Paliperidone ER#969113
- Treatment of Refractory Schizophrenia With Riluzole#850170
- A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder#1164655
Record · ID 1294360
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive